Lingrui Pharma(SH:600285) Zheng Quan Shi Bao Wang·2025-05-09 15:32Group 1 - The fentanyl concept index rose by 0.80%, ranking second among concept sectors, with four stocks increasing in value, including Botao Bio, Lingrui Pharmaceutical, and China National Pharmaceutical Group, which rose by 4.83%, 1.61%, and 1.05% respectively [1] - The leading decliners in the fentanyl sector included Wanfu Biology, Enhua Pharmaceutical, and Renfu Pharmaceutical, which fell by 0.71%, 0.31%, and 0.14% respectively [1] - The overall market saw a net outflow of 0.20 billion yuan from the fentanyl concept sector, with Lingrui Pharmaceutical receiving the highest net inflow of 10.09 million yuan [1] Group 2 - The top stocks in the fentanyl concept based on net capital flow included Lingrui Pharmaceutical with a 1.61% increase and a turnover rate of 0.88%, while Dongfang Bio and Enhua Pharmaceutical experienced slight declines [1] - The net capital outflow for Wanfu Biology and Renfu Pharmaceutical was significant, with outflows of 29.31 million yuan and 66.75 million yuan respectively [1] - The overall performance of the fentanyl concept was contrasted with other sectors, such as the ST sector which rose by 1.11%, while storage chips and DRG/DIP sectors saw declines of 2.67% and 2.66% respectively [1]